Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A N Phillips

Showing results (141-150 of 234) with videos related to

Pageof 24
Sort By:
HIV Medicine|February 27, 2008
An audit of viral load in one clinical population to describe features of viraemic patients on antiretroviral therapyS Madge, C J Smith, F Lampe, et al.
Archives of Internal Medicine|April 8, 1998
Incidence and consequences of pregnancy in women with known duration of HIV infection. Italian Seroconversion Study GroupM B Alliegro, M Dorrucci, A N Phillips, et al.
The Journal of Infectious Diseases|March 18, 2000
Resistance profiles in patients with viral rebound on potent antiretroviral therapyA Cozzi Lepri, C A Sabin, S Staszewski, et al.
The Journal of Infectious Diseases|February 18, 1998
Production of beta-chemokines in human immunodeficiency virus (HIV) infection: evidence that high levels of macrophage inflammatory protein-1beta are associated with a decreased risk of HIV disease progressionH Ullum, A Cozzi Lepri, J Victor, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1991
More rapid progression to AIDS in older HIV-infected people: the role of CD4+ T-cell countsA N Phillips, C A Lee, J Elford, et al.
AIDS Research and Human Retroviruses|August 10, 1997
Low production of interferon gamma is related to disease progression in HIV infection: evidence from a cohort of 347 HIV-infected individualsH Ullum, A Cozzi Lepri, K Bendtzen, et al.
Clinical Trials (London, England)|June 16, 2006
The feasibility of clinical endpoint trials in HIV infection in the highly active antiretroviral treatment (HAART) eraA Mocroft, J Neaton, J Bebchuk, et al.
JAMA|November 28, 2001
HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral loadA N Phillips, S Staszewski, R Weber, et al.
HIV Medicine|July 18, 2015
A simple self-reported adherence tool as a predictor of viral rebound in people with viral suppression on antiretroviral therapyJ L O'Connor, E M Gardner, S Esser, et al.
Journal of Medical Virology|November 20, 1997
HIV-1 dynamics after transient antiretroviral therapy: implications for pathogenesis and clinical managementA N Phillips, A McLean, M A Johnson, et al.
Pageof 24

Showing results (141-150 of 234) with videos related to

Sort By:
Pageof 24
HIV Medicine|February 27, 2008
An audit of viral load in one clinical population to describe features of viraemic patients on antiretroviral therapyS Madge, C J Smith, F Lampe, et al.
Archives of Internal Medicine|April 8, 1998
Incidence and consequences of pregnancy in women with known duration of HIV infection. Italian Seroconversion Study GroupM B Alliegro, M Dorrucci, A N Phillips, et al.
The Journal of Infectious Diseases|March 18, 2000
Resistance profiles in patients with viral rebound on potent antiretroviral therapyA Cozzi Lepri, C A Sabin, S Staszewski, et al.
The Journal of Infectious Diseases|February 18, 1998
Production of beta-chemokines in human immunodeficiency virus (HIV) infection: evidence that high levels of macrophage inflammatory protein-1beta are associated with a decreased risk of HIV disease progressionH Ullum, A Cozzi Lepri, J Victor, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1991
More rapid progression to AIDS in older HIV-infected people: the role of CD4+ T-cell countsA N Phillips, C A Lee, J Elford, et al.
AIDS Research and Human Retroviruses|August 10, 1997
Low production of interferon gamma is related to disease progression in HIV infection: evidence from a cohort of 347 HIV-infected individualsH Ullum, A Cozzi Lepri, K Bendtzen, et al.
Clinical Trials (London, England)|June 16, 2006
The feasibility of clinical endpoint trials in HIV infection in the highly active antiretroviral treatment (HAART) eraA Mocroft, J Neaton, J Bebchuk, et al.
JAMA|November 28, 2001
HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral loadA N Phillips, S Staszewski, R Weber, et al.
HIV Medicine|July 18, 2015
A simple self-reported adherence tool as a predictor of viral rebound in people with viral suppression on antiretroviral therapyJ L O'Connor, E M Gardner, S Esser, et al.
Journal of Medical Virology|November 20, 1997
HIV-1 dynamics after transient antiretroviral therapy: implications for pathogenesis and clinical managementA N Phillips, A McLean, M A Johnson, et al.
Pageof 24